Brief: Athira Pharma Q1 EPS USD -0.69

May 15 (Reuters) - Athira Pharma Q1 operating expenses USD 27.687 million.
* Q1 operating income USD -27.687 million
* Q1 net income USD -26.337 million

Recent news on LeonaBio

See all news